Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19

Download from the WHO Digital Library	These WHO interim recommendations for use of the COVID-19 vaccine Novavax NVX-CoV2373 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes. More information: The Novavax vaccine against COVID-19: What you need to know